Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial. Ehling R, Di Pauli F, Lackner P, Rainer C, Kraus V, Hegen H, Lutterotti A, Kuenz B, De Zordo T, Schocke M, et al. J Neuroimmunol. 2015 Oct 15; 287:98-105. Epub 2015 Aug 10. PMID: 26439969. Abstract CommentRecommendBookmarkWatch